256931-54-1 Usage
Description
3-METHYL-3-AZETIDINOL, also known as 3-Methylazetidin-3-ol, is a chemical compound with a unique structure that features a four-membered nitrogen-containing ring. It is known for its potential applications in the pharmaceutical industry due to its ability to inhibit specific protein targets, making it a promising candidate for the development of therapeutic agents.
Uses
Used in Pharmaceutical Industry:
3-METHYL-3-AZETIDINOL is used as a CDK2 inhibitor for the treatment of cancer. It targets and inhibits the activity of cyclin-dependent kinase 2 (CDK2), a protein that plays a crucial role in cell cycle regulation and is often overexpressed in various types of cancer. By inhibiting CDK2, 3-METHYL-3-AZETIDINOL can help prevent uncontrolled cell proliferation and the growth of cancerous tumors.
Additionally, 3-METHYL-3-AZETIDINOL is used as an IRAK4 inhibitor for the treatment of diseases related to interleukin-1 receptor-associated kinase 4 (IRAK4). IRAK4 is a key signaling molecule involved in the innate immune response and has been implicated in the pathogenesis of various inflammatory and autoimmune diseases. By inhibiting IRAK4, 3-METHYL-3-AZETIDINOL can potentially modulate the immune response and provide therapeutic benefits for patients suffering from such conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 256931-54-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,5,6,9,3 and 1 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 256931-54:
(8*2)+(7*5)+(6*6)+(5*9)+(4*3)+(3*1)+(2*5)+(1*4)=161
161 % 10 = 1
So 256931-54-1 is a valid CAS Registry Number.
InChI:InChI=1/C4H9NO/c1-4(6)2-5-3-4/h5-6H,2-3H2,1H3
256931-54-1Relevant articles and documents
As the NS4B inhibitor benzofuran analogs (by machine translation)
-
Paragraph 0386; 0388; 0389; 0392; 0393, (2016/10/31)
The present invention discloses a kind of as NS4B benzofuran analogue inhibitors, in particular to the formula (I) below or a pharmaceutically acceptable salt thereof. (by machine translation)
PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES AS CGRP RECEPTOR ANTAGONISTS
-
Page/Page column 68-69, (2009/07/25)
The present invention relates to novel compounds that are CGRP receptor antagonists, processes for their preparation, to compositions containing them and to their use in the treatment of migraine, headache, and cluster headache.
OXAZOLIDINONES CONTAINING AZETIDINE AS ANTIBACTERIAL AGENTS
-
Page/Page column 48, (2010/11/25)
The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof wherein R1 and R2 are independently H, F, OH, C1-2alkyl, CF3, OC1-2alkyl, optionally substituted
